Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hepatitis × Steroids × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Myasthenia Gravis 2 Hemangioma 2 Breast Neoplasms 2 Spinal Cord Compression 1 Radiation Injuries 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Hepatitis 1 Head and Neck Neoplasms 1 Gallstones 1 Esophageal Stenosis 1 Esophageal Neoplasms 1 Common Bile Duct Neoplasms 1 Common Bile Duct Diseases 1 Colorectal Neoplasms 1 Chemical and Drug Induced Liver Injury 1 Carcinoma, Hepatocellular 1 Brain Injuries 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Blood Specimen Collection 2 bavituximab 1 Ursodeoxycholic Acid 1 Surveys and Questionnaires 1 Steroids 1 Spermine Synthase 1 Sorafenib 1 Prednisone 1 Phlebotomy 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Liquid Biopsy 1 Clinical Protocols 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡